We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Fields »
 

Field

Term
Gene name

Class

Subclass

Chromosome

External id

In atlas

Reliability

Reliability

Reliability

Validation

Method

Validation

Method

Validation

Method

Validation

Location

Searches

Tissue

Cell type

Expression

Tissue

Specificity

Cell line

Specificity

Tissue

Detectable

Cell line

Detectable

Category

Score

Score

Score

Antibodies

Column

 
 
ABOUT
HELP
BLOG
  • THE HUMAN PROTEOME
  • THE HUMAN TISSUES
  • THE HUMAN CELL
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
    • NEWS
    • BLOG
    • EVENTS
    • PRESS ROOM
    • LEARN
    • DICTIONARY
    • METHODS
    • CELL LINES
  • THE PROJECT
  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • PUBLICATION DATA
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • LINKS
  • CONTACT
  • TECHNICAL DATA
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • DOWNLOADABLE DATA
  • HELP & FAQ
  • LICENCE & CITATION
  • PRIVACY STATEMENT
  • RELEASE HISTORY
FHL2
  • premium

    TISSUE

  • premium

    CELL

  • CANCER

TISSUE ATLAS PRIMARY DATA

GENE/PROTEIN

Antibody validation


Dictionary


Tissue proteome

GENERAL INFORMATION

Gene name

FHL2

Gene description

Four and a half LIM domains 2

Protein class

Predicted intracellular proteins

Predicted localization

Intracellular

Number of transcripts

10
SHOW MORE

HUMAN PROTEIN ATLAS INFORMATION

RNA tissue category

HPA:Expressed in all
GTEx:Tissue enhanced (ovary, heart muscle)
FANTOM5:Group enriched (heart muscle, ovary)

Protein evidence

Evidence at protein level

Protein expression

General cytoplasmic expression, highest in heart muscle, ovary and endometrium.

DATA RELIABILITY

Data reliability
description

Antibody staining mainly consistent with RNA expression data.

Reliability score

Supported based on 3 antibodies.
HPA005922 , HPA006028 , CAB008368
SHOW MORE

RNA AND PROTEIN EXPRESSION SUMMARY

RNA expression (TPM) Protein expression (score)
Brain
Cerebral cortex
Hippocampus
N/A
Caudate
N/A
Cerebellum
N/A
Endocrine tissues
Thyroid gland
Parathyroid gland
Adrenal gland
Bone marrow & immune system
Appendix
Bone marrow
Lymph node
Tonsil
Spleen
Muscle tissues
Heart muscle
Skeletal muscle
Smooth muscle
Lung
Nasopharynx
N/A
Bronchus
N/A
Lung
Liver & gallbladder
Liver
Gallbladder
Pancreas
Pancreas
Gastrointestinal tract
Oral mucosa
N/A
Salivary gland
Esophagus
Stomach
Duodenum
Small intestine
Colon
Rectum
Kidney & urinary bladder
Kidney
Urinary bladder
Male tissues
Testis
Epididymis
Prostate
Seminal vesicle
Female tissues
Breast
Vagina
N/A
Cervix, uterine
Endometrium
Fallopian tube
Ovary
Placenta
Adipose & soft tissue
Adipose tissue
Soft tissue
N/A
Skin
Skin
Cerebral cortex

Lymph node

Heart muscle

Liver

Colon

Kidney

Testis

PROTEIN EXPRESSION OVERVIEW

Organ
Expression
Alphabetical

RNA EXPRESSION OVERVIEW

HPA dataset
Organ
Expression
Alphabetical
RNA tissue category: Expressed in all
GTEx dataset
Organ
Expression
Alphabetical
RNA tissue category: Tissue enhanced (ovary, heart muscle)
FANTOM5 dataset
Organ
Expression
Alphabetical
RNA tissue category: Group enriched (heart muscle, ovary)

GENE INFORMATION

Gene name

FHL2 (HGNC Symbol)

Synonyms

DRAL, SLIM3

Description

Four and a half LIM domains 2 (HGNC Symbol)

Entrez gene summary

This gene encodes a member of the four-and-a-half-LIM-only protein family. Family members contain two highly conserved, tandemly arranged, zinc finger domains with four highly conserved cysteines binding a zinc atom in each zinc finger. This protein is thought to have a role in the assembly of extracellular membranes. Also, this gene is down-regulated during transformation of normal myoblasts to rhabdomyosarcoma cells and the encoded protein may function as a link between presenilin-2 and an intracellular signaling pathway. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Aug 2011]

Chromosome

2

Cytoband

q12.2

Chromosome location (bp)

105357712 - 105438513

Protein evidence

Evidence at protein level (all genes)

Ensembl

ENSG00000115641 (version 83.38)

Entrez gene

2274

UniProt

Q14192 (UniProt - Evidence at protein level)

neXtProt

NX_Q14192

Antibodypedia

FHL2 antibodies

PROTEIN BROWSER

FHL2-001
FHL2-002
FHL2-003
FHL2-004
FHL2-005
FHL2-006
FHL2-007
FHL2-009
FHL2-011
FHL2-201

PROTEIN INFORMATION

Splice variant

UniProt

Protein class

Gene ontology

Length & mass

Signal peptide
(predicted)

Transmembrane regions
(predicted)

FHL2-001
ENSP00000386665
ENST00000409807
Q14192 [Direct mapping]
Four and a half LIM domains protein 2
Q6I9R8 [Target identity:100%; Query identity:100%]
FHL2 protein; Four and a half LIM domains 2; HCG28013, isoform CRA_a; cDNA, FLJ94468, Homo sapiens four and a half LIM domains 2 (FHL2), mRNA
Show all
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter]
GO:0001649 [osteoblast differentiation]
GO:0003713 [transcription coactivator activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005925 [focal adhesion]
GO:0006351 [transcription, DNA-templated]
GO:0006357 [regulation of transcription from RNA polymerase II promoter]
GO:0008134 [transcription factor binding]
GO:0008270 [zinc ion binding]
GO:0009725 [response to hormone]
GO:0015629 [actin cytoskeleton]
GO:0030018 [Z disc]
GO:0030521 [androgen receptor signaling pathway]
GO:0031430 [M band]
GO:0042802 [identical protein binding]
GO:0043066 [negative regulation of apoptotic process]
GO:0044255 [cellular lipid metabolic process]
GO:0044281 [small molecule metabolic process]
GO:0045892 [negative regulation of transcription, DNA-templated]
GO:0045893 [positive regulation of transcription, DNA-templated]
GO:0050681 [androgen receptor binding]
GO:0055014 [atrial cardiac muscle cell development]
GO:0055015 [ventricular cardiac muscle cell development]
GO:0060347 [heart trabecula formation]
Show all
279 aa
32.2 kDa
No 0
FHL2-002
ENSP00000344266
ENST00000344213
J3KNW4 [Direct mapping]
Four and a half LIM domains protein 2
Show all
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005925 [focal adhesion]
GO:0008270 [zinc ion binding]
GO:0015629 [actin cytoskeleton]
Show all
389 aa
44.2 kDa
No 0
FHL2-003
ENSP00000377021
ENST00000393353
Q14192 [Direct mapping]
Four and a half LIM domains protein 2
Q6I9R8 [Target identity:100%; Query identity:100%]
FHL2 protein; Four and a half LIM domains 2; HCG28013, isoform CRA_a; cDNA, FLJ94468, Homo sapiens four and a half LIM domains 2 (FHL2), mRNA
Show all
Predicted intracellular proteins
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter]
GO:0003713 [transcription coactivator activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005925 [focal adhesion]
GO:0006351 [transcription, DNA-templated]
GO:0008134 [transcription factor binding]
GO:0008270 [zinc ion binding]
GO:0009725 [response to hormone]
GO:0015629 [actin cytoskeleton]
GO:0030521 [androgen receptor signaling pathway]
GO:0042802 [identical protein binding]
GO:0043066 [negative regulation of apoptotic process]
GO:0044255 [cellular lipid metabolic process]
GO:0044281 [small molecule metabolic process]
GO:0045893 [positive regulation of transcription, DNA-templated]
GO:0050681 [androgen receptor binding]
Show all
279 aa
32.2 kDa
No 0
FHL2-004
ENSP00000322909
ENST00000322142
Q14192 [Direct mapping]
Four and a half LIM domains protein 2
Q6I9R8 [Target identity:100%; Query identity:100%]
FHL2 protein; Four and a half LIM domains 2; HCG28013, isoform CRA_a; cDNA, FLJ94468, Homo sapiens four and a half LIM domains 2 (FHL2), mRNA
Show all
Predicted intracellular proteins
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter]
GO:0003713 [transcription coactivator activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005925 [focal adhesion]
GO:0006351 [transcription, DNA-templated]
GO:0008134 [transcription factor binding]
GO:0008270 [zinc ion binding]
GO:0009725 [response to hormone]
GO:0015629 [actin cytoskeleton]
GO:0030521 [androgen receptor signaling pathway]
GO:0042802 [identical protein binding]
GO:0043066 [negative regulation of apoptotic process]
GO:0044255 [cellular lipid metabolic process]
GO:0044281 [small molecule metabolic process]
GO:0045893 [positive regulation of transcription, DNA-templated]
GO:0050681 [androgen receptor binding]
Show all
279 aa
32.2 kDa
No 0
FHL2-005
ENSP00000386633
ENST00000408995
Q14192 [Direct mapping]
Four and a half LIM domains protein 2
Q6I9R8 [Target identity:100%; Query identity:100%]
FHL2 protein; Four and a half LIM domains 2; HCG28013, isoform CRA_a; cDNA, FLJ94468, Homo sapiens four and a half LIM domains 2 (FHL2), mRNA
Show all
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter]
GO:0003713 [transcription coactivator activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005925 [focal adhesion]
GO:0006351 [transcription, DNA-templated]
GO:0008134 [transcription factor binding]
GO:0008270 [zinc ion binding]
GO:0009725 [response to hormone]
GO:0015629 [actin cytoskeleton]
GO:0030521 [androgen receptor signaling pathway]
GO:0042802 [identical protein binding]
GO:0043066 [negative regulation of apoptotic process]
GO:0044255 [cellular lipid metabolic process]
GO:0044281 [small molecule metabolic process]
GO:0045893 [positive regulation of transcription, DNA-templated]
GO:0050681 [androgen receptor binding]
Show all
279 aa
32.2 kDa
No 0
FHL2-006
ENSP00000386892
ENST00000409177
A0A0A0MSG2 [Direct mapping]
Four and a half LIM domains protein 2
Show all
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0008270 [zinc ion binding]
Show all
395 aa
44.8 kDa
No 0
FHL2-007
ENSP00000397083
ENST00000447958
C9J3S8 [Direct mapping]
Four and a half LIM domains protein 2
Show all
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
19 aa
2.3 kDa
No 0
FHL2-009
ENSP00000377020
ENST00000393352
Q14192 [Direct mapping]
Four and a half LIM domains protein 2
Q6I9R8 [Target identity:100%; Query identity:100%]
FHL2 protein; Four and a half LIM domains 2; HCG28013, isoform CRA_a; cDNA, FLJ94468, Homo sapiens four and a half LIM domains 2 (FHL2), mRNA
Show all
Predicted intracellular proteins
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter]
GO:0003713 [transcription coactivator activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005925 [focal adhesion]
GO:0006351 [transcription, DNA-templated]
GO:0008134 [transcription factor binding]
GO:0008270 [zinc ion binding]
GO:0009725 [response to hormone]
GO:0015629 [actin cytoskeleton]
GO:0030521 [androgen receptor signaling pathway]
GO:0042802 [identical protein binding]
GO:0043066 [negative regulation of apoptotic process]
GO:0044255 [cellular lipid metabolic process]
GO:0044281 [small molecule metabolic process]
GO:0045893 [positive regulation of transcription, DNA-templated]
GO:0050681 [androgen receptor binding]
Show all
279 aa
32.2 kDa
No 0
FHL2-011
ENSP00000476199
ENST00000607522
U3KQT4 [Direct mapping]
Four and a half LIM domains protein 2
Show all
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0008270 [zinc ion binding]
Show all
65 aa
7.2 kDa
No 0
FHL2-201
ENSP00000350846
ENST00000358129
Q14192 [Direct mapping]
Four and a half LIM domains protein 2
Show all
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter]
GO:0003713 [transcription coactivator activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005925 [focal adhesion]
GO:0006351 [transcription, DNA-templated]
GO:0008134 [transcription factor binding]
GO:0008270 [zinc ion binding]
GO:0009725 [response to hormone]
GO:0015629 [actin cytoskeleton]
GO:0030521 [androgen receptor signaling pathway]
GO:0042802 [identical protein binding]
GO:0043066 [negative regulation of apoptotic process]
GO:0044255 [cellular lipid metabolic process]
GO:0044281 [small molecule metabolic process]
GO:0045893 [positive regulation of transcription, DNA-templated]
GO:0050681 [androgen receptor binding]
Show all
151 aa
15.9 kDa
No 0

Contact

  • BLOG
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • DOWNLOADABLE DATA

The Human Protein Atlas

  • ANTIBODY AVAILABILITY
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.